CAR-T Therapy Leads to Myasthenia Gravis Improvements

(MedPage Today) — SAN FRANCISCO — Descartes-08, an autologous, B-cell maturation antigen (BCMA)-directed mRNA chimeric antigen receptor (CAR) T-cell therapy, led to sustained responses in generalized myasthenia gravis (MG), a phase IIb trial…

Source link : https://www.medpagetoday.com/meetingcoverage/aanem/118230

Author :

Publish date : 2025-10-30 15:36:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

CAR-T Therapy Leads to Myasthenia Gravis Improvements

T-Cell Killer Opens New Approach to Rheumatoid Arthritis

Nanotyrannus: Dinosaur skeleton settles long debate over ‘tiny T. rex’ fossils

Related Posts

No Robust Data Supporting Cannabis for Chronic Nerve Pain

Older Endurance Athletes May Face Increased Arrhythmia Risk

Nephropathy Dominates Diabetes Comorbidity Profile in Nepal

Screening all UK children for type 1 diabetes would be effective, study says

Why doing a mix of exercise could be the key to longer life

Bubble feeding trick spreads through humpback whale social groups

No Robust Data Supporting Cannabis for Chronic Nerve Pain

Older Endurance Athletes May Face Increased Arrhythmia Risk

Nephropathy Dominates Diabetes Comorbidity Profile in Nepal

Screening all UK children for type 1 diabetes would be effective, study says

Why doing a mix of exercise could be the key to longer life

Bubble feeding trick spreads through humpback whale social groups

Cross-training may be the key to a long life

Air Pollution Tied to Greater ALS Risk, Worse Outcomes

Categories

Archives